Related references
Note: Only part of the references are listed.Inter- and Intra-individual Variation, and Limited Prognostic Utility, of Serum Alkaline Phosphatase in a Trial of Patients With Primary Sclerosing Cholangitis
Palak J. Trivedi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
Present and future role of endoscopic retrograde cholangiography in primary sclerosing cholangitis
A. Waldthaler et al.
EUROPEAN JOURNAL OF MEDICAL GENETICS (2021)
EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis-2021 update
Annalisa Berzigotti et al.
JOURNAL OF HEPATOLOGY (2021)
Fluctuating biomarkers in primary sclerosing cholangitis: A longitudinal comparison of alkaline phosphatase, liver stiffness, and ELF
Guri Fossdal et al.
JHEP REPORTS (2021)
An update on primary sclerosing cholangitis epidemiology, outcomes and quantification of alkaline phosphatase variability in a population-based cohort
Zeinab Bakhshi et al.
JOURNAL OF GASTROENTEROLOGY (2020)
Soluble Urokinase Receptor and Acute Kidney Injury
Salim S. Hayek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Soluble Urokinase Plasminogen Activator Receptor (suPAR) Concentrations Are Elevated in Patients with Neuroendocrine Malignancies
Burcin Oezdirik et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Circulating levels of soluble urokinase plasminogen activator receptor predict outcome after resection of biliary tract cancer
Sven H. Loosen et al.
JHEP REPORTS (2020)
British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis
Michael Huw Chapman et al.
GUT (2019)
Neutrophils are a main source of circulating suPAR predicting outcome in critical illness
Hendrik Gussen et al.
JOURNAL OF INTENSIVE CARE (2019)
A novel prognostic model for transplant-free survival in primary sclerosing cholangitis
Elisabeth M. de Vries et al.
GUT (2018)
Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos)
Seiki Kiriyama et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2018)
Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline
Lars Aabakken et al.
ENDOSCOPY (2017)
Primary sclerosing cholangitis - a comprehensive review
Tom H. Karlsen et al.
JOURNAL OF HEPATOLOGY (2017)
Alkaline phosphatase at diagnosis of primary sclerosing cholangitis and 1 year later: evaluation of prognostic value
Elisabeth M. G. de Vries et al.
LIVER INTERNATIONAL (2016)
Primary Sclerosing Cholangitis
Konstantinos N. Lazaridis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Serum soluble urokinase-type plasminogen activator receptor as a biological marker of bacterial infection in adults: a systematic review and meta-analysis
Wentao Ni et al.
SCIENTIFIC REPORTS (2016)
ACG Clinical Guideline: Primary Sclerosing Cholangitis
Keith D. Lindor et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
suPAR: A New Biomarker for Cardiovascular Disease?
Gethin W. Hodges et al.
CANADIAN JOURNAL OF CARDIOLOGY (2015)
Biomarkers for disease progression of primary sclerosing cholangitis
Elisabeth M. G. de Vries et al.
CURRENT OPINION IN GASTROENTEROLOGY (2015)
Soluble urokinase plasminogen activator receptor levels are associated with severity of fibrosis in nonalcoholic fatty liver disease
Christopher Sjowall et al.
TRANSLATIONAL RESEARCH (2015)
Review article: controversies in the management of primary biliary cirrhosis and primary sclerosing cholangitis
T. H. Karlsen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Reduction in alkaline phosphatase is associated with longer survival in primary sclerosing cholangitis, independent of dominant stenosis
C. Rupp et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Baseline Values and Changes in Liver Stiffness Measured by Transient Elastography Are Associated With Severity of Fibrosis and Outcomes of Patients With Primary Sclerosing Cholangitis
Christophe Corpechot et al.
GASTROENTEROLOGY (2014)
An Optimized Patient-reported Ulcerative Colitis Disease Activity Measure Derived from the Mayo Score and the Simple Clinical Colitis Activity Index
Meenakshi Bewtra et al.
INFLAMMATORY BOWEL DISEASES (2014)
Serum soluble urokinase plasminogen activator receptor in alcoholics: Relation to liver disease severity, fibrogenesis, and alcohol use
Heidi Tuomi et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
Clinical relevance and cellular source of elevated soluble urokinase plasminogen activator receptor (suPAR) in acute liver failure
Alexander Koch et al.
LIVER INTERNATIONAL (2014)
Pathogenesis of Primary Sclerosing Cholangitis and Advances in Diagnosis and Management
John E. Eaton et al.
GASTROENTEROLOGY (2013)
Soluble urokinase plasminogen activator receptor is compartmentally regulated in decompensated cirrhosis and indicates immune activation and short-term mortality
H. W. Zimmermann et al.
JOURNAL OF INTERNAL MEDICINE (2013)
Primary sclerosing cholangitis
Gideon M. Hirschfield et al.
LANCET (2013)
Soluble urokinase plasminogen activator receptor in plasma is associated with incidence of CVD. Results from the Malmo Diet and Cancer Study
M. Persson et al.
ATHEROSCLEROSIS (2012)
suPAR as a prognostic biomarker in sepsis
Katia Donadello et al.
BMC MEDICINE (2012)
Cholangiocarcinoma and dominant strictures in patients with primary sclerosing cholangitis: a 25-year single-centre experience
Michael H. Chapman et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2012)
Soluble Urokinase Plasminogen Activator Receptor is Associated With Progressive Liver Fibrosis in Hepatitis C Infection
Marie-Luise Berres et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2012)
Circulating soluble urokinase plasminogen activator is elevated in patients with chronic liver disease, discriminates stage and aetiology of cirrhosis and predicts prognosis
Henning W. Zimmermann et al.
LIVER INTERNATIONAL (2012)
Soluble urokinase plasminogen activator receptor suPAR as a marker for inflammation in pediatric inflammatory bowel disease
Kaija-Leena Kolho et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2012)
Blood chemistry markers for evaluation of inflammatory activity in Crohn's disease during infliximab therapy
Maria H. Lonnkvist et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2011)
Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients
Alexander Koch et al.
CRITICAL CARE (2011)
Diagnosis and Management of Primary Sclerosing Cholangitis
Roger Chapman et al.
HEPATOLOGY (2010)
Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population
J. Eugen-Olsen et al.
JOURNAL OF INTERNAL MEDICINE (2010)
Regulation of cell signalling by uPAR
Harvey W. Smith et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
suPAR: The molecular crystal ball
Maria Thuno et al.
DISEASE MARKERS (2009)
Multiple activities of a multifaceted receptor: roles of cleaved and soluble uPAR
Nunzia Montuori et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis
Gerda Rudolph et al.
JOURNAL OF HEPATOLOGY (2009)
EASL Clinical Practice Guidelines: Management of cholestatic liver diseases
Ulrich Beuers et al.
JOURNAL OF HEPATOLOGY (2009)
Evaluation of plasma urokinase-type plasminogen activator and urokinase-type plasminogen-activator receptor in patients with acute and chronic hepatitis B
Huanqin Zhou et al.
THROMBOSIS RESEARCH (2009)
Immunomodulatory effects of plasminogen activators on hepatic fibrogenesis
A. A. Higazi et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2008)
C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study
M. Henriksen et al.
GUT (2008)
Modification of kidney barrier function by the urokinase receptor
Changli Wei et al.
NATURE MEDICINE (2008)
Diagnostic accuracy of the aspartate aminotransferaseto-platelet ratio index for the prediction of hepatitis c-related fibrosis: A systematic review
Abdel Aziz M. Shaheen et al.
HEPATOLOGY (2007)
Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis
J. J. W. Tischendorf et al.
ENDOSCOPY (2006)
Development and validation of a multiplex add-on assay for sepsis biomarkers using xMAP technology
Kristian Kofoed et al.
CLINICAL CHEMISTRY (2006)
Predicting the Crohn's disease activity index from the Harvey-Bradshaw index
WR Best
INFLAMMATORY BOWEL DISEASES (2006)
Oratory markers in IBD: Magic, or unneccessary toys?
S Vermeire et al.
GUT (2006)
Systematic review: the model for end-stage liver disease - should it replace Child-Pugh's classification for assessing prognosis in cirrhosis?
E Cholongitas et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C
CT Wai et al.
HEPATOLOGY (2003)
uPAR: A versatile signalling orchestrator
F Blasi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Inflammatory bowel disease
DK Podolsky
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid:: outcome after endoscopic treatment
A Stiehl et al.
JOURNAL OF HEPATOLOGY (2002)
Soluble urokinase plasminogen activator receptor measurements:: Influence of sample handling
R Riisbro et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2001)
The urokinase plasminogen activator receptor (uPAR) as a target for the diagnosis and therapy of cancer
AP Mazar
ANTI-CANCER DRUGS (2001)
Practices of liver biopsy in France: Results of a prospective nationwide survey
JF Cadranel et al.
HEPATOLOGY (2000)
Share Paper
